Access cutting-edge pulmonary hypertension treatment through this clinical trial at a research site in Phoenix. Study-provided care at no cost to qualified participants.
Access pulmonary hypertension specialists in Phoenix at no cost
This study follows strict safety protocols and ethical guidelines
All study-related pulmonary hypertension treatment provided free
Researchers are looking for new ways to treat people with a type of pulmonary hypertension called combined postcapillary and precapillary pulmonary hypertension (Cpc-PH). This study focuses on Cpc-PH that is caused by heart failure with preserved ejection fraction (HFpEF). Researchers want to know if the study treatment, sotatercept, can treat people with Cpc-PH caused by HFpEF. This is an extension study, which means people who took part in a certain study on sotatercept for Cpc-PH (called a p
Sponsor: Merck Sharp & Dohme LLC
Check if you qualify for this pulmonary hypertension clinical trial in Phoenix, AZ
If you're searching for pulmonary hypertension treatment options in Phoenix, AZ, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Phoenix research site is actively enrolling participants for this clinical trial. You'll receive care from experienced pulmonary hypertension specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.